{"id":"meloxicam-and-glucosamine","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL599","moleculeType":"Small molecule","molecularWeight":"351.41"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits COX-2, reducing prostaglandin synthesis and thereby decreasing inflammation and pain. Glucosamine is an aminomonosaccharide that serves as a precursor for glycosaminoglycan synthesis in cartilage, potentially slowing cartilage breakdown and supporting joint structure. Together, this combination addresses both acute inflammatory symptoms and underlying cartilage health in osteoarthritis.","oneSentence":"Meloxicam reduces inflammation and pain by inhibiting cyclooxygenase enzymes, while glucosamine supports cartilage structure and may reduce joint degradation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:49:51.580Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Osteoarthritis pain and inflammation"}]},"trialDetails":[{"nctId":"NCT03936192","phase":"PHASE3","title":"A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2019-01","conditions":"Knee Osteoarthritis","enrollment":""},{"nctId":"NCT02448199","phase":"PHASE3","title":"Study of Association of Anti-inflammatory and Anti-rheumatic","status":"UNKNOWN","sponsor":"Zodiac Produtos Farmaceuticos S.A.","startDate":"2015-07","conditions":"Osteoarthritis","enrollment":375}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Association Anti-inflamatory/Anti-rheumatic"],"phase":"phase_3","status":"active","brandName":"Meloxicam and Glucosamine","genericName":"Meloxicam and Glucosamine","companyName":"Zodiac Produtos Farmaceuticos S.A.","companyId":"zodiac-produtos-farmaceuticos-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Meloxicam reduces inflammation and pain by inhibiting cyclooxygenase enzymes, while glucosamine supports cartilage structure and may reduce joint degradation. Used for Osteoarthritis pain and inflammation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}